Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sparrow Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Sparrow Pharmaceuticals

Sparrow Pharmaceuticals

Series A

Sparrow Pharmaceuticals: Innovating targeted therapies for corticosteroid excess conditions.

HQ
Portland, OR, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to innovate targeted therapies for conditions of corticosteroid excess, Sparrow Pharmaceuticals focuses on addressing unmet needs in endocrinology and rheumatology. The company’s core product, SPI-62, is currently in Phase 2 clinical development and aims to treat endocrine disorders caused by the overproduction of cortisol. Leveraging proprietary HSD-inhibitor technology, Sparrow's approach combines clofutriben with prednisolone to offer a novel solution for patients suffering from the adverse effects of long-term corticosteroid use.

Sparrow Pharmaceuticals has attracted notable investors and industry experts who support its groundbreaking work in cellular biology and steroid management. Key achievements include advancing SPI-62 through critical clinical trial phases and gaining recognition for its innovative approach to treating cortisol-related conditions. The company's impact lies in its potential to revolutionize treatment protocols, offering new hope to patients who suffer from the debilitating effects of corticosteroid excess.

Sparrow Pharmaceuticals - Similar Companies

Spiral Therapeutics logo

Spiral Therapeutics

spiraltx.com

Spyryx Biosciences logo

Spyryx Biosciences

Corcept Therapeutics logo

Corcept Therapeutics

corcept.com

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

Spruce Biosciences logo

Spruce Biosciences

sprucebio.com

Synspira logo

Synspira

Spyre Therapeutics logo

Spyre Therapeutics

aeglea.com

SphynKx Therapeutics logo

SphynKx Therapeutics

Sapir Pharmaceuticals logo

Sapir Pharmaceuticals

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Sporos Bioventures logo

Sporos Bioventures

Sparo logo

Sparo

sparohealth.com

Spero Therapeutics logo

Spero Therapeutics

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Sparrow Pharmaceuticals - Quick Facts

Who are Sparrow Pharmaceuticals' competitors?

Companies similar to Sparrow Pharmaceuticals include Spiral Therapeutics, Spyryx Biosciences, Corcept Therapeutics and Osprey Pharmaceuticals USA.

When was Sparrow Pharmaceuticals founded?

Sparrow Pharmaceuticals was founded in 2013.

Where is Sparrow Pharmaceuticals' headquarters located?

Sparrow Pharmaceuticals' headquarters is located in Portland, OR, US.

When was Sparrow Pharmaceuticals' last funding round?

Sparrow Pharmaceuticals' most recent funding round was for $50M (USD) in May 2021.

How much has Sparrow Pharmaceuticals raised to-date?

As of May 18, 2021, Sparrow Pharmaceuticals has raised a total of $51.1M (USD).

How many employees does Sparrow Pharmaceuticals have?

Sparrow Pharmaceuticals has 8 employees as of Feb 5, 2024.

Sparrow Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapies
Tags
  • Biotech
  • Healthtech
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified